NKTR
Nektar Therapeutics · Healthcare
President and CEO Howard W Robin sold $29K of Nektar Therapeutics
Sold$29,138
$1.75Price
16,650Shares
−2%Stake
What NKTR did after the filing
- The stock from Tue, May 21 open, $26.10
- −25.9%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Jul 5 close.
Traded Fri, May 17. Filed Mon, May 20, 5:14 PM ET, after the close. Returns use the May 21 open and the Jul 5 close. Not investment advice.